Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
Biomarkers are needed to monitor tuberculosis (TB) treatment and predict treatment outcomes. We evaluated the Xpert MTB/RIF (Xpert) assay as a biomarker for TB treatment during and at the end of the 24 weeks therapy.Sputum from 108 HIV-negative, culture-positive pulmonary TB patients was analyzed us...
Main Authors: | Shubhada Shenai, Katharina Ronacher, Stefanus Malherbe, Kim Stanley, Magdalena Kriel, Jill Winter, Thomas Peppard, Charles E Barry, Jing Wang, Lori E Dodd, Laura E Via, Clifton E Barry, Gerhard Walzl, David Alland |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4980126?pdf=render |
Similar Items
-
Evaluation of Xpert MTB/RIF assay for the diagnosis of paediatric TB
by: F. Ismail, et al.
Published: (2014-04-01) -
Diagnosis of extrapulmonary TB: Experience with the Xpert MTB/Rif assay
by: C.N. Govind, et al.
Published: (2014-04-01) -
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
by: Julia V. Ershova, et al.
Published: (2020-07-01) -
Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
by: Katherine Antel, et al.
Published: (2020-01-01) -
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis.
by: Anna H van't Hoog, et al.
Published: (2013-01-01)